This study is an 8-week evaluation of an investigational drug for treating depression in
bipolar patients. Depressed patients will be given either an investigational drug or placebo
and receive psychiatric assessments of their depression at weekly visits. Study drug and all
study-related visits are provided at no cost to the patient. The patient agrees to meet with
study research staff for roughly 11 clinic visits.